Today: 3 April 2026
Philip Morris stock price watch: PM ends higher after 2026 outlook as Zyn rivalry heats up
8 February 2026
1 min read

Philip Morris stock price watch: PM ends higher after 2026 outlook as Zyn rivalry heats up

NEW YORK, Feb 8, 2026, 14:42 EST — The market is shut.

  • Philip Morris ended the session at $182.81, up 0.45%, following its earnings and outlook update.
  • Zyn nicotine pouches delivered a bump in volumes, though promotions and competition remained front and center.
  • Eyes now turn to Monday’s open for any follow-through, with April’s next earnings checkpoint already on the radar.

Philip Morris International finished Friday’s session at $182.81, up 0.45%, as the market weighed fresh quarterly numbers and the company’s 2026 guidance before trading picks up again Monday. Reuters

Markets are closed Sunday. The immediate question: will the stock keep its post-results gains, or will fresh chatter about stiffer competition in nicotine pouches shove costs and margins back into the spotlight?

Smoke-free products now sit at the heart of the bullish argument for the company. Every Zyn pouch and IQOS heated tobacco update lands with extra weight—price cuts and promos show up in the figures, and investors react.

PMI booked adjusted earnings of $1.70 per share for the fourth quarter, on net revenues totaling $10.36 billion, the company reported Friday. For 2026, PMI is targeting adjusted EPS between $8.38 and $8.53, alongside an “organic” net revenue growth estimate of 5% to 7%—a figure that strips out currency swings and M&A impacts. First-quarter adjusted profit is pegged at $1.80 to $1.85 a share. CEO Jacek Olczak put full-year net revenues above $40 billion, “including close to $17 billion from our smoke-free business.” Zyn’s quarterly shipment volume? 196 million cans, up more than 19%. pmi.com

But the nicotine-pouch narrative for the company has hit some twists. According to Reuters, PMI investors have been on edge as competitors like British American Tobacco make strides in the pouch segment. CEO Olczak said PMI stands ready to roll out new Zyn versions, though that depends on getting regulatory green lights. Jefferies’ Andrei Andon-Ionita described PMI’s latest targets as a “reassuring outlook” despite the heated rivalry. Reuters

The action on Friday underscored the back-and-forth: shares swung from $178.00 up to $186.55, finally closing at $182.81. Volume landed at roughly 8.6 million shares. Investing.com

PMI submitted its earnings release to the SEC on Form 8-K, dated Feb. 6, according to a filing. SEC

The risks are easy enough to spot. Heavier discounting or ramped-up promos to protect pouch share might squeeze margins, and any rollout of new products or expansion is still on hold while regulators in major markets take their time.

All eyes now shift to April 21, when the company will post Q1 results. Investors are expected to zero in on U.S. pouch volumes, pricing strategy, and what it’s taking to maintain market share. pmi.com

Stock Market Today

  • Sun Pharma Shares Under Pressure After Trump Imposes Tariffs on Imported Drugs
    April 3, 2026, 4:11 AM EDT. Sun Pharma shares will be closely watched after President Trump issued an executive order imposing 100% tariffs on imported branded pharmaceuticals unless manufacturers cut prices or produce locally. Although generic drugs are exempt and some big pharma firms have negotiated to avoid tariffs, mid-sized companies like Sun Pharma face risks. Jefferies notes Sun Pharma earns about 20% of its revenue from innovative drugs produced mainly in South Korea, the EU, or the U.S.-regions subject to a 15% tariff, capping potential impact. The stock dropped nearly 2% to ₹1,694.65 on April 2 but showed signs of buying interest Friday, suggesting possible short-term recovery towards ₹1,730-₹1,750. Immediate support is at ₹1,640, key for sustaining any rebound.
PetroChina A-shares jump, but oil headlines and China CPI could decide the next move
Previous Story

PetroChina A-shares jump, but oil headlines and China CPI could decide the next move

Moutai stock price: iMoutai refund crackdown and overnight maintenance put 600519 in focus before Shanghai open
Next Story

Moutai stock price: iMoutai refund crackdown and overnight maintenance put 600519 in focus before Shanghai open

Go toTop